Adlai Nortye: Recapitalized, Refocused, But Still Too Early To Upgrade [Seeking Alpha]
Adlai Nortye Ltd. (ANL)
Company Research
Source: Seeking Alpha
ANL's recent PIPE financings and the ASK Pharm payment also considerably shored up their balance sheet. Today, AN9025 appears to be ANL's main strategic asset, but it remains in Phase 1 and needs stronger clinical validation. Palupiprant is the most advanced active program, though I suspect management doesn't consider it its main focus. Lastly, ANL's valuation seems reasonable at just 1.6x its post-PIPE cash balances. But its IP still needs more data to warrant a bullish upgrade at this stage. Valerii Apetroaiei/iStock via Getty Images Adlai Nortye Ltd. ( ANL ) is a small biopharmaceutical company that develops preclinical/early-stage candidates in oncology. Specifically, they're working on AN9025 for RAS-mutated solid tumors, AN4035 for solid tumors, and AN8025 for advanced tumors. ANL's AN4005 is another small
Show less
Read more
Impact Snapshot
Event Time:
ANL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANL alerts
High impacting Adlai Nortye Ltd. news events
Weekly update
A roundup of the hottest topics
ANL
News
- Adlai Nortye (ANL) had its "buy" rating reaffirmed by HC Wainwright.MarketBeat
- Adlai Nortye Announces $150.0 Million Private Placement Equity FinancingGlobeNewswire
- Adlai Nortye (ANL) is now covered by Leerink Partners. They set an "outperform" rating and a $23.00 price target on the stock.MarketBeat
- Adlai Nortye (ANL) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=ANL&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> to "hold".MarketBeat
- Adlai Nortye (NASDAQ:ANL) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating.MarketBeat
ANL
Sec Filings
- 4/29/26 - Form 3
- 4/29/26 - Form EFFECT
- 4/24/26 - Form F-3/A
- ANL's page on the SEC website